KIMS - Technical Analysis with Chart Patterns & Indicators

Last Updated Time : 19 Sept 25, 2:16 pm

Technical Rating: 3.6

Here’s a comprehensive technical analysis of Krishna Institute of Medical Sciences Ltd. (KIMS)

📊 Trend Overview

Current Trend: 🔼 Trending Upward

Price is trading above both the 50-DMA (₹734) and 200-DMA (₹655), indicating a bullish structure.

The 52-week index at 82.3% shows the stock is near its yearly high of ₹798, reflecting sustained strength.

Despite a slight dip in quarterly profit, the price action remains resilient.

📈 Moving Averages

50-DMA: ₹734 — Short-term support.

200-DMA: ₹655 — Long-term support.

Price Action: Current price of ₹741 is above both DMAs, reinforcing bullish sentiment.

📉 Momentum Indicators

RSI (14-day): 48.0 — Neutral zone, suggesting consolidation or a pause in momentum.

MACD: 3.08 — Bullish crossover, but with a flat slope indicating limited momentum.

Volume: 3.53 lakh vs 1-week avg of 2.97 lakh — Slightly above average, indicating mild accumulation.

📊 Bollinger Bands

Price is likely near the middle band — moderate volatility.

No squeeze or breakout pattern detected, but setup favors continuation if RSI improves.

📌 Support & Resistance Zones

Level Price (₹) Commentary

Support 1 734 50-DMA, short-term support

Support 2 710 Previous swing low

Resistance 1 765 Minor resistance zone

Resistance 2 798 52-week high, major resistance

🎯 Entry & Exit Zones

Optimal Entry: ₹730–₹740 — On pullback near 50-DMA.

Exit Zone: ₹765–₹795 — Resistance zone for profit booking.

🔍 Short-Term Signals

Momentum: Stabilizing — MACD bullish, RSI neutral.

Breakout Potential: Moderate — Watch for RSI push above 55 and volume surge.

Bias: Cautiously bullish — Trend intact, but momentum needs confirmation.

🧭 Summary

KIMS is currently trending upward, supported by price action above key moving averages and a positive MACD. However, RSI and volume trends suggest mild consolidation. Traders may consider entering near ₹730–₹740 and targeting ₹765–₹795 for exits. A breakout above ₹765 with RSI >55 and volume confirmation could signal further upside.

Let me know if you'd like a comparison with other hospital or healthcare stocks for broader context.

Edit in a page